REDEFINE 2 was a double-blind, randomized, placebo-controlled 68-week efficacy and safety phase 3 trial of once-weekly CagriSema versus placebo in 1,206 adults with type 2 diabetes and either obesity or overweight
If symptoms appear, we can adjust timing, dose, or supportive care
While we deliver our service 100% virtually, our medically supervised approach ensures you receive personalized tips and structure for integrating mobility, flexibility, strength, and cardio into a successful routine
You probably have certain hopes when you go on a GLP-1 medication like Wegovy, which is FDA-approved for weight management
Now they are back where they started, $15,000 poorer considering starting the cycle Compare that to the patient who spent $12,500 once on a sleeve lost 60-70% of their excess weight and kept it off